Troy Tazbaz, CDRH digital health leader, resigns
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...
MassDevice9d
FDA selects a CDRH official as acting commissioner
Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of the agency.
FierceBiotech5d
FDA digital director Troy Tazbaz departs the agency
The head of the FDA’s artificial-intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency ...
JD Supra2d
How New Executive Orders May Affect FDA’s Medical Device Operations
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
medtechdive9d
FDA webpages on clinical trial diversity removed after Trump orders
The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...
GlobalData on MSN6d
FDA issues cybersecurity risk alert over Contec patient monitor
The FDA says the cybersecurity vulnerabilities identified may put patients at risk when the device is connected to the ...
JD Supra9d
FDA Dumps Trio of Device-Related Guidances Prior to Administration Change
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
manilatimes2d
Transparency Notifications from Shareholders
(1) The total number of outstanding shares of the Company on 24 January 2025 mentioned in the relevant transparency notifications amounts to 52,416,601, each share giving right to one (1) vote (being ...
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares following Loan Conversions
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNTAND NEW NUMBER OF SHARES FOLLOWING LOAN CONVERSIONSConversion of EUR 0.53 million under the ...